C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome

The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.

Inclusion Criteria:

• Mayo Clinic patients with a previously confirmed infection with the novel SARS-CoV-2 virus who have been seen in the Post COVID Clinic through GIM Integrative Medicine & Health Section or approval by MAGPIES research group.
• Be able to participate fully in all aspects of the study.
• Have understood and signed study informed consent.

Exclusion Criteria:

• Lacking the capacity to consent.

• Prisoners and institutionalized individuals.

• Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the LLLT treatment phase and are unwilling to use a reliable form of contraception.

  o Acceptable forms include:

  • Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants
  • Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm)
  • Intrauterine device (IUD)
  • Total hysterectomy or tubal ligation
  • Abstinence (no sex).

• Those patients that have implants that would prevent them from having a PET Scan.

• Patients that have claustrophobia.

• Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.